These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1732635)

  • 1. Interferon-alpha can alter the lytic susceptibility of murine bladder transitional cell carcinoma (MBT-2) by their original poor specific cytotoxic tumor infiltrating lymphocytes.
    Tzai TS; Lin SN
    J Urol; 1992 Feb; 147(2):523-7. PubMed ID: 1732635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating the antitumor immunity of MBT-2 murine bladder tumor bearing mice by postoperative administration of interferon-alpha.
    Tzai TS; Shiau AL; Wu CL; Chow NH; Tsai YS
    Anticancer Res; 1998; 18(5A):3355-61. PubMed ID: 9858908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma.
    Belldegrun A; Pierce W; Kaboo R; Tso CL; Shau H; Turcillo P; Moldawer N; Golub S; deKernion J; Figlin R
    J Urol; 1993 Nov; 150(5 Pt 1):1384-90. PubMed ID: 8411405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
    Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
    Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
    Mizutani Y; Yoshida O
    J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.
    Schendel DJ; Gansbacher B
    Cancer Res; 1993 Sep; 53(17):4020-5. PubMed ID: 8358731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of interleukin-12 against murine bladder cancer.
    Eto M; Harada M; Tamada K; Tokuda N; Koikawa Y; Nakamura M; Nomoto K; Naito S
    J Urol; 2000 May; 163(5):1549-52. PubMed ID: 10751886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene modification of bladder cancer cells for the establishment of bladder cancer vaccine.
    Saito S; Tazaki H; Heston WD; Fair WR
    Int J Urol; 1996 Jan; 3(1 Suppl):S35-9. PubMed ID: 24304018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of specific anti-tumour immunity by interferon-gamma gene-transferred murine bladder carcinoma MBT-2.
    Hiura M; Hashimura T; Watanabe Y; Kuribayashi K; Yoshida O
    Folia Biol (Praha); 1994; 40(1-2):49-61. PubMed ID: 7958064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
    Akbasak A; Oldfield EH; Saris SC
    J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
    Pryor K; Goddard J; Goldstein D; Stricker P; Russell P; Golovsky D; Penny R
    Br J Cancer; 1995 Apr; 71(4):801-7. PubMed ID: 7710947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 expanded tumor-infiltrating lymphocytes and their response to preoperative alpha-interferon in patients with renal cell carcinoma.
    Fujioka T; Yoshida N; Hasegawa M; Ishikura K; Suzuki Y; Kubo T
    J Urol; 1994 Sep; 152(3):852-6. PubMed ID: 8051734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guérin (BCG): A role of BCG internalization into tumor cells.
    Ikeda N; Toida I; Iwasaki A; Kawai K; Akaza H
    Int J Urol; 2002 Jan; 9(1):29-35. PubMed ID: 11972647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
    Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
    J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative administration of interleukin-12 significantly enhances the anti-tumor immune response of MBT-2 bladder cancer bearing mice.
    Tzai TS; Shiau AL; Wu CL; Tsai YS
    Proc Natl Sci Counc Repub China B; 2000 Apr; 24(2):56-62. PubMed ID: 10809081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
    Wang YL; Si LS; Kanbour A; Herberman RB; Whiteside TL
    Cancer Res; 1989 Nov; 49(21):5979-85. PubMed ID: 2507139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.